Chemical activators of FAM135A include a variety of compounds that influence different signaling pathways leading to the activation of this protein. Phorbol 12-myristate 13-acetate (PMA) is a potent activator of protein kinase C (PKC), which in turn can phosphorylate FAM135A, thereby activating it. The increase in cAMP levels by Forskolin leads to the activation of PKA, another kinase capable of targeting and activating FAM135A through phosphorylation. Similarly, Ionomycin, by raising intracellular calcium levels, activates calcium-dependent kinases that may also phosphorylate and thereby activate FAM135A. The activation of the EGF receptor by Epidermal Growth Factor initiates the MAPK/ERK signaling cascade, which is capable of phosphorylating FAM135A, leading to its activation. Insulin, by activating the PI3K/AKT pathway, could also bring about the phosphorylation and activation of FAM135A. Moreover, Hydrogen Peroxide functions as a signaling molecule in redox reactions and can activate kinases that target and phosphorylate FAM135A, leading to its activation.
Continuing with the activation mechanisms, Anisomycin, which activates stress-activated MAPK pathways such as JNK and p38, can phosphorylate FAM135A, promoting its activation. Dibutyryl-cAMP, a cAMP analog, similarly activates PKA that then phosphorylates and activates FAM135A. Okadaic Acid, a phosphatase inhibitor, indirectly activates FAM135A by preventing its dephosphorylation, thereby maintaining FAM135A in an active state. Bisindolylmaleimide I, under specific conditions, can have a paradoxical activation effect on PKC, leading to phosphorylation and activation of FAM135A. The donor of nitric oxide, S-Nitroso-N-acetylpenicillamine (SNAP), can activate soluble guanylate cyclase and subsequent PKG activation, which can phosphorylate and activate FAM135A. Lastly, Calyculin A, also a phosphatase inhibitor, ensures that FAM135A remains phosphorylated and active by inhibiting the enzymes that would otherwise dephosphorylate and deactivate it. Each of these chemicals interacts with specific kinases or signaling pathways that ultimately lead to the functional activation of FAM135A.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA directly activates protein kinase C (PKC), which is known to phosphorylate a multitude of proteins, including FAM135A, resulting in its functional activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium concentrations, which can activate calcium-dependent protein kinases that could phosphorylate and activate FAM135A. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the PI3K/AKT signaling pathway, which could lead to the phosphorylation and subsequent activation of FAM135A. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $31.00 $61.00 $95.00 | 28 | |
As a signaling molecule in oxidative stress pathways, Hydrogen Peroxide can activate kinases that target and activate FAM135A. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates MAPK pathways such as JNK and p38, which could result in the phosphorylation and functional activation of FAM135A. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP, a cAMP analog, activates PKA which can then phosphorylate and activate FAM135A. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid inhibits phosphatases like PP1 and PP2A, leading to sustained phosphorylation and activation of associated proteins, including FAM135A. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Although primarily a PKC inhibitor, Bisindolylmaleimide I can activate PKC under certain conditions, leading to the phosphorylation and activation of FAM135A. | ||||||
(±)-S-Nitroso-N-acetylpenicillamine | 79032-48-7 | sc-200319B sc-200319 sc-200319A | 10 mg 20 mg 100 mg | $74.00 $114.00 $374.00 | 18 | |
SNAP releases nitric oxide, which can activate soluble guanylate cyclase and PKG, kinases that could phosphorylate and activate FAM135A. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A, by inhibiting phosphatases, can maintain proteins like FAM135A in a phosphorylated and active state. | ||||||